Furthermore, ExoASO-STAT6 showed potent antitumor activity in both mouse tumor models (> 90% inhibition of tumor growth), whereas free ASO at equivalent drug doses did not exhibit any therapeutic effects (Fig. 12A) [205]. Here, STAT6 is linked to neoplasm.